Copertina

The mIR-302 cluster is silenced upon differentiation to the mechanosensory lineage.

Fuente: Zenodo

Salvato in:

Dettagli Bibliografici
Autore principale:	Mamoor, Shahan
Natura:	Recurso digital
Pubblicazione:	Zenodo 2026
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

A retrotransposon-like gene, RTL5, is modulated during differentiation of embryonic stem cells to the trophectoderm lineage.
di: Mamoor, Shahan
Pubblicazione: (2026)

Gasdermin activation during lineage specification in the human embryo.
di: Mamoor, Shahan
Pubblicazione: (2026)

Nuclear factors that govern endotoxin tolerance in the myeloid lineage.
di: Mamoor, Shahan
Pubblicazione: (2025)

Androgen signaling has functions in lineage commitment in the human embryo.
di: Mamoor, Shahan
Pubblicazione: (2026)

H7N9 PA-X silences Ifi6.
di: Mamoor, Shahan
Pubblicazione: (2026)

Casz1 mobilization during TE lineage specification from the pluripotent state in embryonic stem cells.
di: Mamoor, Shahan
Pubblicazione: (2026)

Haglr, a HOXD antisense growth-associated long non-coding RNA with functions in lineage commitment in the human embryo.
di: Mamoor, Shahan
Pubblicazione: (2026)

LOC107984343, a TE differentiation-associated product.
di: Mamoor, Shahan
Pubblicazione: (2026)

Unbiased discovery of genes required for pluripotency: Terf1.
di: Mamoor, Shahan
Pubblicazione: (2026)

Major differences between HPV+ and HPV- head and neck cancer.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDK4.
di: Mamoor, Shahan
Pubblicazione: (2026)

Disparate immune receptor control by p53 sufficient and p53 deficient cancers.
di: Mamoor, Shahan
Pubblicazione: (2026)

An expression screen to identify genes important for trastuzumab resistance: Pax8-as1.
di: Mamoor, Shahan
Pubblicazione: (2026)

An expression screen to identify genes important for trastuzumab resistance: Ccl19.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CNTNAP2.
di: Mamoor, Shahan
Pubblicazione: (2026)

Feedback activation of VEGF-A resulting from PAX8 inhibition in cancer cells.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: EIF4G1.
di: Mamoor, Shahan
Pubblicazione: (2026)

Gpr84 is a marker of the inflammatory bowel disease Crohn's Disease.
di: Mamoor, Shahan
Pubblicazione: (2026)

An epigenetic module common to the T lymphocyte.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ERO1A.
di: Mamoor, Shahan
Pubblicazione: (2026)

A relationship between p53 and Braf in mammalian cells.
di: Mamoor, Shahan
Pubblicazione: (2026)

Fam234b is selectively activated during the first cell division of the human embryo.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CPAMD8.
di: Mamoor, Shahan
Pubblicazione: (2026)

Rip kinase expression during early development in humans.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDC45.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ENPP3.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CMC2.
di: Mamoor, Shahan
Pubblicazione: (2026)

An expression screen to identify genes important for trastuzumab resistance: Meox2.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: DNAAF5.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: EFNA4.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CHORDC1.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: FAM129B.
di: Mamoor, Shahan
Pubblicazione: (2026)

Deletion of repeat B and C of Xist results in induction of SATB1.
di: Mamoor, Shahan
Pubblicazione: (2026)

Arid5b is activated early in human embryonic development.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: DEPDC1.
di: Mamoor, Shahan
Pubblicazione: (2026)

NLRP7 engagement in transformation and etiology of chronic disease.
di: Mamoor, Shahan
Pubblicazione: (2025)

The range of Xist transcriptional targets in non-small cell lung cancer: BTBD7.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: AIM1.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: TGFBI.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: AFM.
di: Mamoor, Shahan
Pubblicazione: (2025)